Immediate Impact
1 from Science/Nature 55 standout
Citing Papers
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
2024 Standout
Works of León Litwak being referenced
Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| León Litwak | 446 | 105 | 106 | 116 | 34 | 614 | |
| J.P. Gutai | 513 | 119 | 46 | 124 | 18 | 719 | |
| Kelly Bell | 380 | 110 | 71 | 37 | 34 | 701 | |
| Licia Denti | 241 | 83 | 78 | 56 | 34 | 697 | |
| Anat Jaffe | 478 | 60 | 92 | 30 | 24 | 699 | |
| Stanley H. Hsia | 456 | 173 | 139 | 118 | 25 | 731 | |
| Ankit Shah | 243 | 170 | 124 | 38 | 41 | 631 | |
| Glenn Matfin | 341 | 183 | 125 | 36 | 42 | 682 | |
| Shi‐Wen Kuo | 288 | 181 | 69 | 41 | 39 | 665 | |
| Mette Axelsen | 253 | 142 | 94 | 76 | 20 | 642 | |
| Philip E. Knapp | 603 | 146 | 57 | 197 | 17 | 722 |
All Works
Loading papers...